Skip to content

A Comparative Investigation of Efficacy and Complications in Light and Deep Chemical Peels

A Comparative Investigation of Efficacy and Complications in Light and Deep Chemical Peels

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06749561
Enrollment
112
Registered
2024-12-27
Start date
2024-02-01
Completion date
2025-03-01
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peeling Skin Syndrome

Brief summary

Chemical peeling involves applying substances to the skin to induce controlled damage, which promotes the regeneration of fresh skin cells and enhances the skin's appearance.

Detailed description

This study will be a cross-sectional analysis with a sample size of 112 patients.

Interventions

DIAGNOSTIC_TESTGroup 1

To Compare the safety and effectiveness of boyh types

Sponsors

Superior University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy males and females aged 18-35 years. * Willing to provide informed consent and follow the treatment protocol.

Exclusion criteria

* Pregnant or breastfeeding women. * Active skin conditions (e.g., acne, eczema). * Use of medications that affect skin healing. * Known allergies to chemical peel substances.

Design outcomes

Primary

MeasureTime frameDescription
Dermatological Assessment Score (DAS)12 MonthsThe area-wise percentage involvement of the involved sites is calculated as: 1 = less than 10% area; 2 = 10-29%; 3 = 30-49%; 4 = 50-69%; 5 = 70-89%; and 6 = more than 90%. The maximum score of PASI is 72. PASI 75 is a 75% reduction of baseline PASI score.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026